Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 18 04:00PM ET
0.9126
Dollar change
+0.0593
Percentage change
6.95
%
Index- P/E- EPS (ttm)-5.73 Insider Own5.74% Shs Outstand11.17M Perf Week-9.64%
Market Cap10.20M Forward P/E2.44 EPS next Y0.37 Insider Trans0.00% Shs Float10.53M Perf Month18.52%
Income-43.10M PEG- EPS next Q-0.59 Inst Own5.69% Short Float6.31% Perf Quarter-43.32%
Sales0.00M P/S- EPS this Y66.50% Inst Trans-0.63% Short Ratio0.32 Perf Half Y-67.29%
Book/sh6.92 P/B0.13 EPS next Y118.67% ROA-39.63% Short Interest0.66M Perf Year-94.16%
Cash/sh0.00 P/C340.00 EPS next 5Y- ROE-60.06% 52W Range0.65 - 26.25 Perf YTD-77.19%
Dividend Est.- P/FCF- EPS past 5Y20.90% ROIC-70.14% 52W High-96.52% Beta0.85
Dividend TTM- Quick Ratio0.06 Sales past 5Y- Gross Margin- 52W Low40.40% ATR (14)0.18
Dividend Ex-Date- Current Ratio0.37 EPS Y/Y TTM3.17% Oper. Margin- RSI (14)51.52 Volatility8.81% 13.90%
Employees23 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.67 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q5.27% Payout- Rel Volume0.32 Prev Close0.85
Sales Surprise- EPS Surprise-231.33% Sales Q/Q- EarningsMay 14 AMC Avg Volume2.06M Price0.91
SMA207.93% SMA507.96% SMA200-79.75% Trades Volume657,271 Change6.95%
Date Action Analyst Rating Change Price Target Change
Dec-30-24Upgrade D. Boral Capital Hold → Buy $9
Nov-30-21Initiated Maxim Group Buy $4
Jun-17-25 08:08AM
Jun-12-25 09:00AM
08:35AM
Jun-10-25 07:00AM
Jun-09-25 08:37AM
04:30PM Loading…
May-14-25 04:30PM
May-05-25 08:37AM
Apr-01-25 09:00AM
Feb-14-25 04:30PM
Feb-06-25 08:55AM
Jan-08-25 08:00AM
Jan-07-25 08:08AM
07:57AM
Jan-06-25 07:50AM
Dec-31-24 07:10AM
09:43AM Loading…
Dec-30-24 09:43AM
Dec-29-24 10:50PM
Dec-27-24 05:00PM
Nov-25-24 08:03AM
Nov-22-24 09:00AM
Nov-18-24 04:05PM
Nov-15-24 01:30PM
Nov-11-24 08:45AM
Sep-05-24 04:30PM
08:30AM
Aug-13-24 09:30AM
04:32AM
Aug-12-24 10:53PM
05:28PM
04:22PM
08:00AM Loading…
08:00AM
Aug-09-24 07:30AM
Aug-08-24 05:41PM
06:59AM
Aug-05-24 08:00AM
08:00AM
Jul-18-24 07:00AM
Jul-17-24 08:00AM
Jul-11-24 11:00AM
08:00AM
Jul-10-24 09:10AM
Jul-07-24 09:01AM
Jun-11-24 10:50AM
May-29-24 08:30AM
May-21-24 11:42AM
11:20AM
10:58AM
07:00AM
May-14-24 10:55PM
04:05PM
May-10-24 08:30AM
Apr-30-24 04:05PM
Apr-26-24 10:43AM
08:00AM
Apr-11-24 08:30AM
Apr-04-24 08:30AM
Mar-18-24 08:30AM
Mar-12-24 10:30AM
Mar-07-24 08:30AM
Feb-26-24 07:30AM
Feb-23-24 08:30AM
Feb-15-24 09:17AM
Feb-14-24 04:30PM
08:01AM
Jan-23-24 08:30AM
Jan-02-24 08:31AM
08:30AM
Nov-14-23 08:55AM
Nov-09-23 08:30AM
Oct-31-23 08:45AM
Oct-24-23 07:30AM
Sep-21-23 09:35AM
Sep-18-23 04:30PM
Sep-13-23 04:30PM
Sep-08-23 08:00AM
Sep-06-23 04:30PM
Aug-14-23 04:15PM
Aug-10-23 08:37AM
Jul-29-23 04:16PM
Jun-26-23 08:30AM
Jun-20-23 04:09PM
08:30AM
Jun-13-23 08:30AM
May-12-23 04:30PM
May-08-23 01:42PM
May-04-23 08:00AM
Apr-24-23 09:10AM
Apr-03-23 08:00AM
Mar-30-23 08:30AM
Mar-27-23 09:52AM
Mar-13-23 09:15AM
Mar-08-23 08:30AM
Feb-10-23 04:30PM
Feb-06-23 10:30AM
Jan-17-23 10:00AM
Jan-16-23 07:09AM
Jan-11-23 08:30AM
Dec-28-22 09:35AM
Dec-22-22 04:30PM
Dec-01-22 07:30AM
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.